Genetic and biochemical analyses in dyslipidemic patients undergoing LDL apheresis-Reference-Cited by-同舟云学术

Genetic and biochemical analyses in dyslipidemic patients undergoing LDL apheresis

Published:2014-01-13 Issue:5 Volume:29 Page:256-265
ISSN:0733-2459
Container-title:Journal of Clinical Apheresis
language:en
Short-container-title:J. Clin. Apheresis

Author:

Donato Leslie J.¹,Saenger Amy K.¹,Train Laura J.¹,Kotzer Katrina E.¹,Lagerstedt Susan A.¹,Hornseth Jean M.¹,Basu Ananda²,Winters Jeffrey L.¹,Baudhuin Linnea M.¹

Affiliation:

1. Department of Laboratory Medicine and Pathology; Mayo Clinic; Rochester Minnesota

2. Division of Endocrinology; Mayo Clinic; Rochester Minnesota

Publisher

Wiley

Subject

Hematology,General Medicine

Reference31 articles.

1. Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia). A study of its biochemical, genetic and clinical presentation in childhood;Kwiterovich;J Clin Invest,1974

2. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia;Goldberg;J Clin Lipidol,2011

3. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia;Goldberg;J Clin Lipidol,2011

4. Low-density lipoprotein apheresis: principles and indications;Winters;Semin Dial,2012

5. Lipid apheresis, indications, and principles;Winters;J Clin Apher,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tissue and Serum Biomarkers in Degenerative Aortic Stenosis-Insights into Pathogenesis, Prevention and Therapy;Biology;2023-02-22

2. Risk of Non-Alcoholic Fatty Liver Disease in Xanthelasma Palpebrarum;Journal of Inflammation Research;2021-05

3. Genetic considerations in the treatment of familial hypercholesterolemia;Clinical Lipidology;2015-10-01

4. Effects of lipoprotein apheresis on PCSK9 levels;Atherosclerosis Supplements;2015-05